SEC Form 4 · accession 0001209191-17-046876
REATA PHARMACEUTICALS INC · RETA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Edward Bass
Director
Period of report
Aug 1, 2017
Accepted (ET)
Aug 1, 2017 · 1:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A common stockF1 | Aug 1, 2017 | P | 8,064 | $31.00 | A | 67,411 | D | |
| Class A common stock | holding | — | — | — | 41,902 | I | By Bass Family Trust A | |
| Class A common stock | holding | — | — | — | 17,555 | I | By Bass Trust FBO James E. Bass |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Due to the conditions to closing of the public offering of the Class A common stock, these purchases were not deemed to occur until closing, on August 1, 2017.